TSX News -
ProMIS Neurosciences’ Neil Cashman to Speak at Protein Misfolding Drug Discovery Conference
ProMIS’ proprietary drug discovery and development platform highlighted for ability to create novel antibodies, diagnostics and vaccine candidates for neurodegenerative […]